Articles Tagged With:
-
Insulin: A Primer
With the continued development of “smarter” pumps, the management of one of the most common chronic conditions is becoming safer and more effective.
-
Emergency Psychiatry Update
This issue of Emergency Medicine Reports will review several changes in the recently released Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) — i.e., specifically those changes most relevant to emergency physicians. We also provide an update on some of the newest medications for depression. -
An Update on Sepsis Clinical Research: Impact on ED Management
The authors review the ups and downs of several landmark sepsis studies from the past 15 years. Their findings are reaffirming and powerful.
-
Where Are Salaries Highest for Emergency Medicine Physicians?
Three states report the highest compensation for emergency medicine physicians. This is where the science and the business of medicine collide.
-
Quality Family Planning (QFP) — Put it into practice
“Providing Quality Family Planning Services — Recommendations of CDC and the U.S. Office of Population Affairs” is the newest member in the “suite” of family planning recommendations from the Centers for Disease Control and Prevention. -
Where should teens access condoms?
On the most recent Youth Risk Behavior Survey (YRBS), 40% of sexually active U.S. high school students reported that they did not use a condom at last intercourse. This percentage has significantly declined since 1991 when the survey began but has increased since a low of 37% in 2003.1 Additionally, in 2013 less than 10% of students reported dual use of condoms plus a hormonal method.
-
Despite new options, oral contraceptive pills are still in birth control mix, survey respondents say
How are oral contraceptives being used in today’s family planning practices? The Affordable Care Act (ACA) might be making a difference when it comes to use of the Pill. Between 2012 and 2013, the number of women who filled prescriptions for the Pill with no co-pay more than quadrupled from 1.2 million to 5.1 million, according to data from the IMS Institute for Healthcare Informatics in Parsippany, NJ, an information and technology service.
-
Oral contraceptives — Should they be OTC?
When it comes to moving oral contraceptives over the counter (OTC), almost 50% of participants in the Contraceptive Technology Update Contraception Survey say they support such a move. Support for OTC access is growing; 62% of American women support the pill being available without a prescription.
-
With unsurpassed efficacy and rapid reversibility, contraceptive implant can be put into practice
While use of long-acting reversible contraceptive (LARC) methods is growing, the contraceptive implant (Nexplanon, Merck & Co., Whitehouse Station, NJ) is still underused, say family planning experts. Look at the most recent national figures: In 2009, 8.5% of women using contraceptives relied on LARC methods, rising from 5.5% in 2007 and 2.4% in 2002. However, most of these women (nearly 8%) use intrauterine devices (IUDs), compared to less than 1% who use the implant.
-
Ortho Evra patch discontinued — What next?
Rewind to 2002: The first transdermal contraceptive, the Ortho Evra patch, hit U.S. pharmacy shelves. Fast forward to the present: The manufacturer has production of the device “due to a business decision,” according to information on the Food and Drug Administration (FDA) website.